This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
Go Fund Yourself: Rewriting the Ride & Rethinking the Exam Room
WAXii builds a driver-first rideshare for underserved markets starting in the Caribbean. Mylo redesigns medical tools for dignity, comfort & care efficiency.
Netflix Walks Away! Paramount in Lead to Scoop up Warner Bros. Discovery
Netflix Walks Away! Paramount in Lead to Scoop up Warner Bros. Discovery
Heart-Pounding Finish: Why This Beast Games Finale Changes Everything
Sean Klitzner, showrunner and co-creator of Beast Games, previews the Feb. 25 finale packed with bigger stunts, wild twists, and the highest stakes yet.
Inside the Explosive Case Accusing Social Media of Harming Kids
Maria Curi, tech policy reporter at Axios, breaks down Meta’s landmark trial as Zuckerberg testifies in a case that could reshape tech accountability.
McGraw Hill Posts Strong Q3 Growth Amid Digital and AI Push
Bob Sallmann, CFO of McGraw Hill, breaks down the quarter’s standout performance, digital expansion, and how AI tools are driving education innovation.
Starfighters Space’s Tim Franta on Rockets, Supersonic Flights, And Market Edge
Franta explains what sets Starfighters Space apart from competitors and how the company is shaping the next generation of spaceflight.
